Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genital Diseases, Male”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01616485
What this trial is testing

Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

Who this might be right for
Erectile Dysfunction
VIVUS LLC 106
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Not applicableStudy completedNCT04936243
What this trial is testing

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Who this might be right for
Breast CancerProstate CancerPatient Engagement+2 more
Dana-Farber Cancer Institute 30
Not applicableUnknownNCT04060589
What this trial is testing

ReIMAGINE Prostate Cancer Risk

Who this might be right for
Prostate Cancer
University College, London 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05806515
What this trial is testing

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8
SWOG Cancer Research Network 44
Testing effectiveness (Phase 2)Study completedNCT00087035
What this trial is testing

Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 1
Not applicableStudy completedNCT02353715
What this trial is testing

Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing

Who this might be right for
Prostate Cancer
Duke University 38
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Not applicableUnknownNCT03658525
What this trial is testing

Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)

Who this might be right for
Prostate Cancer
Royal Marsden NHS Foundation Trust 30
Not applicableStudy completedNCT01571076
What this trial is testing

Preimplantation Genetic Screening (PGS) in Advanced Female Age and Male Severe Factor

Who this might be right for
Embryo AneuploidiesImplantation RatesInfertility
Igenomix 240
Not applicableActive Not RecruitingNCT00578240
What this trial is testing

Molecular Studies and Clinical Correlations in Human Prostatic Disease

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5,290
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Not applicableLooking for participantsNCT07463508
What this trial is testing

Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

Who this might be right for
Testicular Germ Cell Cancer
University Hospital, Clermont-Ferrand 20
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Large-scale testing (Phase 3)Study completedNCT00540891
What this trial is testing

The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score

Who this might be right for
Benign Prostatic Hyperplasia
Sanofi 372
Not applicableLooking for participantsNCT06691776
What this trial is testing

Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)

Who this might be right for
Prostate CancerCervical CancerBladder Cancer+2 more
The Netherlands Cancer Institute 100
Not applicableUnknownNCT04661176
What this trial is testing

Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico

Who this might be right for
Prostate Cancer
miR Scientific LLC 500
Large-scale testing (Phase 3)Study completedNCT01152190
What this trial is testing

A Study in Benign Prostatic Hyperplasia

Who this might be right for
Benign Prostatic Hyperplasia
Eli Lilly and Company 97
Testing effectiveness (Phase 2)Looking for participantsNCT06616597
What this trial is testing

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Next Page